Fusion Antibodies plc Obtains Canadian Patent for OptiMAL® Antibody Library Technology

Fusion Antibodies plc Obtains Canadian Patent for OptiMAL® Antibody Library Technology →

Fusion Antibodies plc (AIM: FAB), the Belfast-based contract research organisation specialising in pre-clinical antibody discovery and engineering, has announced that the Canadian Intellectual Property Office has officially granted its pate…